ATE411395T1 - Verfahren zur identifizierung und/oder validierung von rezeptortyrosinkinase-inhibitoren - Google Patents
Verfahren zur identifizierung und/oder validierung von rezeptortyrosinkinase-inhibitorenInfo
- Publication number
- ATE411395T1 ATE411395T1 AT03753198T AT03753198T ATE411395T1 AT E411395 T1 ATE411395 T1 AT E411395T1 AT 03753198 T AT03753198 T AT 03753198T AT 03753198 T AT03753198 T AT 03753198T AT E411395 T1 ATE411395 T1 AT E411395T1
- Authority
- AT
- Austria
- Prior art keywords
- tyrosine kinase
- validation
- inhibitors
- host cells
- kinase activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CH2003/000694 WO2005040413A1 (en) | 2003-10-24 | 2003-10-24 | Method for the identification and/or validation of receptor tyrosine kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE411395T1 true ATE411395T1 (de) | 2008-10-15 |
Family
ID=34468779
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03753198T ATE411395T1 (de) | 2003-10-24 | 2003-10-24 | Verfahren zur identifizierung und/oder validierung von rezeptortyrosinkinase-inhibitoren |
Country Status (11)
Country | Link |
---|---|
US (1) | US7566528B2 (de) |
EP (1) | EP1675961B1 (de) |
JP (1) | JP2007508801A (de) |
AT (1) | ATE411395T1 (de) |
AU (1) | AU2003271489B2 (de) |
CA (1) | CA2544074A1 (de) |
DE (1) | DE60324207D1 (de) |
DK (1) | DK1675961T3 (de) |
IL (1) | IL175097A0 (de) |
NZ (1) | NZ547398A (de) |
WO (1) | WO2005040413A1 (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1675961B1 (de) | 2003-10-24 | 2008-10-15 | Oncalis AG | Verfahren zur identifizierung und/oder validierung von rezeptortyrosinkinase-inhibitoren |
EP1778858A4 (de) * | 2004-01-15 | 2009-08-19 | Univ Washington | Unter verwendung von drosophila an pharmazeutika durchgeführtes screening mit hohem durchsatz |
US20060156421A1 (en) * | 2004-06-18 | 2006-07-13 | Cagan Ross L | High throughput screening methods for anti-metastatic compounds |
EP1715059A1 (de) * | 2005-04-21 | 2006-10-25 | Esbatech AG | Verfahren zur Erkennung von möglichen gesundheitsgefährdenden Rezeptortyrosinkinase-Mutationen und von Inhibitoren oder Medikamenten gegen RTK-Mutanten |
WO2006111035A1 (en) * | 2005-04-21 | 2006-10-26 | Oncalis Ag | Method for the identification of possibly harmful receptor tyrosine kinase (rtk) mutations and of inhibitors or medication directed against rtk mutantstitle |
JP5554925B2 (ja) * | 2006-01-20 | 2014-07-23 | セル・シグナリング・テクノロジー・インコーポレイテツド | ヒト非小細胞肺癌における転座及び変異体rosキナーゼ |
JP5392992B2 (ja) * | 2007-03-30 | 2014-01-22 | アズワン株式会社 | 自己リン酸化受容体のアゴニスト、アンタゴニストのスクリーニング方法、遺伝子組換え酵母 |
US20090226442A1 (en) * | 2008-01-22 | 2009-09-10 | Biogen Idec Ma Inc. | RON antibodies and uses thereof |
GB0900425D0 (en) * | 2009-01-12 | 2009-02-11 | Ucb Pharma Sa | Biological products |
KR101433057B1 (ko) | 2012-03-07 | 2014-09-23 | 한국과학기술원 | 빛에 의해 rtk 신호전달을 활성화하는 융합단백질 및 그의 용도 |
EP2789630A1 (de) | 2013-04-09 | 2014-10-15 | EngMab AG | Bispezifische Antikörper gegen CD3e und ROR1 |
US10231965B2 (en) | 2014-02-20 | 2019-03-19 | Ignyta, Inc. | Molecules for administration to ROS1 mutant cancer cells |
PL3137114T3 (pl) | 2014-04-30 | 2021-06-28 | Pfizer Inc. | Koniugaty przeciwciało anty-ptk7-lek |
ES2850325T3 (es) | 2014-10-09 | 2021-08-27 | Engmab Sarl | Anticuerpos biespecíficos contra CD3epsilon y ROR1 |
WO2016089760A1 (en) | 2014-12-02 | 2016-06-09 | Ignyta, Inc. | Combinations for the treatment of neuroblastoma |
CN107849113B (zh) * | 2015-05-29 | 2022-03-22 | 亚尼塔公司 | 用于治疗具有rtk突变细胞的患者的组合物和方法 |
CA3008663A1 (en) | 2015-12-18 | 2017-06-22 | Ignyta, Inc. | Combinations of a selective tyrosine kinase inhibitor (tki) with a mek or erk inhibitor for the treatment of cancer |
BR112020000793A2 (pt) | 2017-07-19 | 2020-07-14 | Ignyta, Inc. | composições farmacêuticas e formas de dosagem |
WO2019077506A1 (en) | 2017-10-17 | 2019-04-25 | Ignyta, Inc. | PHARMACEUTICAL COMPOSITIONS AND SOLID GALENIC FORMS |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0624192A1 (de) * | 1992-01-22 | 1994-11-17 | New England Deaconess Hospital | Neue Protein Tyrosinkinasen |
US6051397A (en) * | 1993-11-16 | 2000-04-18 | Max Planck Gesellschaft Zur Forderung Der Wissenschaften | DNA encoding MCK-10, a novel receptor tyrosine kinase |
US5573994A (en) * | 1994-05-13 | 1996-11-12 | University Of Cincinnati | Superabsorbent foams, and method for producing the same |
US5573944A (en) * | 1994-07-22 | 1996-11-12 | President And Fellows Of Harvard College | Yeast cell expressing heterologous receptor kinase |
US6433154B1 (en) * | 1997-06-12 | 2002-08-13 | Bristol-Myers Squibb Company | Functional receptor/kinase chimera in yeast cells |
AU2003218236B2 (en) * | 2002-03-01 | 2007-12-06 | Bristol-Myers Squibb Company | Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors |
EP1495329B1 (de) * | 2002-04-18 | 2006-03-29 | Esbatech AG | Verfahren zum nachweis von modulatoren einer sekretaseaktivität |
EP1675961B1 (de) | 2003-10-24 | 2008-10-15 | Oncalis AG | Verfahren zur identifizierung und/oder validierung von rezeptortyrosinkinase-inhibitoren |
-
2003
- 2003-10-24 EP EP03753198A patent/EP1675961B1/de not_active Expired - Lifetime
- 2003-10-24 NZ NZ547398A patent/NZ547398A/en unknown
- 2003-10-24 AU AU2003271489A patent/AU2003271489B2/en not_active Ceased
- 2003-10-24 DE DE60324207T patent/DE60324207D1/de not_active Expired - Lifetime
- 2003-10-24 JP JP2005509767A patent/JP2007508801A/ja active Pending
- 2003-10-24 AT AT03753198T patent/ATE411395T1/de not_active IP Right Cessation
- 2003-10-24 WO PCT/CH2003/000694 patent/WO2005040413A1/en active Application Filing
- 2003-10-24 DK DK03753198T patent/DK1675961T3/da active
- 2003-10-24 CA CA002544074A patent/CA2544074A1/en not_active Abandoned
-
2005
- 2005-04-22 US US11/112,344 patent/US7566528B2/en not_active Expired - Fee Related
-
2006
- 2006-04-23 IL IL175097A patent/IL175097A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20050239049A1 (en) | 2005-10-27 |
EP1675961A1 (de) | 2006-07-05 |
WO2005040413A1 (en) | 2005-05-06 |
US7566528B2 (en) | 2009-07-28 |
EP1675961B1 (de) | 2008-10-15 |
AU2003271489A1 (en) | 2005-05-11 |
JP2007508801A (ja) | 2007-04-12 |
DE60324207D1 (de) | 2008-11-27 |
CA2544074A1 (en) | 2005-05-06 |
AU2003271489B2 (en) | 2009-02-19 |
DK1675961T3 (da) | 2009-02-23 |
NZ547398A (en) | 2008-10-31 |
IL175097A0 (en) | 2006-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL175097A0 (en) | Method for the identification and/or validation of receptor tyrosine kinase inhibitors | |
ATE507305T1 (de) | Verfahren zur nukleinsäureimmobilisierung | |
DE602005021336D1 (de) | Verfahren zur identifizierung von proteinen mit stärkephosphorylierender enzymatischer aktivität | |
BRPI0513308A (pt) | sistemas e métodos de análise de polìmeros de ácido nucléico e componentes relacionados | |
DE60023936D1 (de) | Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen | |
NO20074389L (no) | Bestemmelse av respondere til kjemoterapi | |
UA93989C2 (ru) | Способ прогнозирования otbeta ha лечение | |
DE60028732D1 (de) | Verfahren zur erhaltung der dns-integrität | |
ATE494388T1 (de) | Neues verfahren zum erschaffen von proteinkinase- inhibitoren | |
DE59912716D1 (de) | Verfahren zur bestimmung der immunabwehraktivität des blutes sowie testkit hierfür | |
ATE433591T1 (de) | Authentifizierungsverfahren für einen gegenstand oder stoff durch markierung oder chemische verfolgbarkeit | |
DE602004015791D1 (de) | Screening-Verfahren zur Identifizierung von Tau-Protein modulierenden Substanzen. | |
Kjellerup et al. | Pro‐inflammatory cytokine release in keratinocytes is mediated through the MAPK signal‐integrating kinases | |
ATE426806T1 (de) | Verfahren zur prognose der wirksamkeit von chemotherapie | |
ATE532072T1 (de) | Verfahren und vorrichtung zur beurteilung von polypeptidaggregation | |
DE602004017884D1 (de) | Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren | |
ATE405592T1 (de) | Verfahren zur bildung eines protein- mikroarraysystems | |
ATE483724T1 (de) | Verfahren zur erhöhung der ausbreitung von b- zellen | |
DE602004026759D1 (de) | Neue rekombinante tierzellen mit hoher proteinproduktion, verfahren zur konstruktion davon sowie verfahren zur massenproduktion von protein unter verwendung davon | |
DE602005018808D1 (de) | Odifizierung der supercoil-topologie von nukleinsäuren sowie modulatoren | |
DE60320302D1 (de) | Verfahren zur identifikation von modulatoren des humanen orexin-2-rezeptors | |
DE60326640D1 (de) | Rekombinante biotincarboxylasedomänen zur identifizierung von acetyl-coa-carboxylase-inhibitoren | |
ATE359513T1 (de) | Hochdurchsatzscreening von verbindungen für biologische wirksamkeit | |
DE602005005663D1 (de) | Verfahren zur charakterisierung von verbindungen | |
DE602004019180D1 (de) | Methode zur Identifizierung von unbekannten Proteinen mittels zwei-dimensionaler Auftrennung und Verwendung von Markern |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1675961 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |